Shaoqiang Li

State Key Laboratory Of Respiratory Disease
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Corrigendum to "Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990-2021: A systematic analysis of the global burden of disease study 2021″ [J Infect 93 (2026) 106768].

Corrigendum to "Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990-2021: A systematic analysis of the global burden of disease study 2021″ [J Infect 93 (2026) 106768].

Journal: The Journal of infection

Published: August 22, 2026

Emergence of a high-risk multidrug-resistant Acinetobacter baumannii clone ST697 in nosocomial settings.

Emergence of a high-risk multidrug-resistant Acinetobacter baumannii clone ST697 in nosocomial settings.

Journal: Microbiology spectrum

Published: April 16, 2026

Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990-2021: A systematic analysis of the global burden of disease study 2021.

Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990-2021: A systematic analysis of the global burden of disease study 2021.

Journal: The Journal of infection

Published: April 16, 2026

KL-6 assisted subtyping of ARDS: from subtype-specific metabolomics to LPCAT1 as a pathogenic target.

KL-6 assisted subtyping of ARDS: from subtype-specific metabolomics to LPCAT1 as a pathogenic target.

Journal: Respiratory research

Published: October 17, 2025

Machine learning prediction of antibiotic resistance in Gram-negative pneumonia: a clinical-genomic integrated model.

Machine learning prediction of antibiotic resistance in Gram-negative pneumonia: a clinical-genomic integrated model.

Journal: BMC microbiology

Published: August 15, 2025

The association between albumin-corrected anion gap and in-hospital mortality in critically ill COPD patients: A multicenter retrospective study from eICU collaborative research database.

The association between albumin-corrected anion gap and in-hospital mortality in critically ill COPD patients: A multicenter retrospective study from eICU collaborative research database.

Journal: Journal of critical care

Published: June 03, 2025

Characteristics of polyclonal anti-interferon-gamma autoantibodies and novel diagnostic strategies: A prospective cohort study of new biomarkers.

Characteristics of polyclonal anti-interferon-gamma autoantibodies and novel diagnostic strategies: A prospective cohort study of new biomarkers.

Journal: Journal of translational autoimmunity

Published: April 10, 2025

Factors influencing the prevalence and death rate of COPD: a pan-database ecological study covering 201 countries and regions from 1990 to 2021.

Factors influencing the prevalence and death rate of COPD: a pan-database ecological study covering 201 countries and regions from 1990 to 2021.

Journal: EClinicalMedicine

Published: April 10, 2025

One-step diagnosis of infection and lung cancer using metagenomic sequencing.

One-step diagnosis of infection and lung cancer using metagenomic sequencing.

Journal: Respiratory research

Published: July 31, 2024

Efficacy and safety of caspofungin for the treatment of invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Efficacy and safety of caspofungin for the treatment of invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Journal: The Journal of international medical research

Published: March 26, 2024

Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study.

Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study.

Journal: Frontiers in pharmacology

Published: March 15, 2024

Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.

Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.

Journal: Frontiers in cellular and infection microbiology

Published: February 15, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026